Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/09/680
Active ingredient: 5'-O-(trans-9''-octadecenoyl)-1-beta-D-2'-deoxy-2',2'-difluorocytidine
Indication: Treatment of pancreatic cancer
Sponsor: Clovis Oncology UK Limited
Sheraton House, Castle Park, Castle Hill, Cambridge CB3 0AX, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/10/2009 Centralised Orphan - Designation EMEA/OD/067/09 (2009)5823 of 28/10/2009
21/06/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/067/09/T/01 (2010)4212 of 17/06/2010
11/03/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/067/09/T/02 (2011)1687 of 09/03/2011
29/04/2013 Centralised Orphan - Removal of orphan designation from Community Register